title: Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability.
authors.affiliation: Molecular and Cellular Biology Division of Diabetes, Endocrinology and Metabolism, Baylor College of Medicine, Houston, Texas, USA. agarber@bcm.tmc.edu
authors.forename: Alan J
authors.initials: AJ
authors.lastname: Garber
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D000077270:Exenatide; D052216:Glucagon-Like Peptide 1 / Q000009:adverse effects / Q000819:agonists* / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000069450:Liraglutide; D010455:Peptides / Q000009:adverse effects / Q000627:therapeutic use; D014688:Venoms / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide